The latest news and updates about NYSCF and our collaborators
Scientific progress is dependent on many factors, and one critical component is public engagement. The public relies on biomedical research to advance solutions for pressing health...
The Context: INAD is a rare neurological disease affecting children, often referred to as a “pediatric Parkinson’s,” which is typically diagnosed between six months to three...
The Context: ALS is a disease that manifests differently in each patient, with some cases resulting from genetic predispositions, and others sporadically. Because the causes can...
The Context: All our blood cells are created in the bone marrow by blood-forming stem cells, and when this process goes awry, leukemia can arise. Scientists...
The Context: Turning patient stem cells into the different cell types of the brain offers immense promise for studying and treating neurodegenerative diseases such as Alzheimer’s,...
What goes into successful disease research? Scientists, of course, who design and conduct experiments. Patients, who generously offer to donate their cells or participate in clinical...
Earlier this month, NYSCF hosted an intimate conversation with Interim CEO Derrick Rossi, PhD, who shared the journey of his already long and storied career in...
“I moved to New York in 2006, exactly when [Shinya] Yamanaka made the groundbreaking discovery of induced pluripotent stem cells, which was completely revolutionizing the way...
As NYSCF enters 2023, we’re taking a moment to look back at the defining moments of 2022. Whether it was gathering in person again for our...
We hear a lot about the importance of promoting diversity and creating inclusive cultures in the workplace, but why does it matter for science? Why should...
The Context: As we listen to the world around us, our brains can tell us when something doesn’t sound right – i.e. the wrong music note,...
The Context: When someone builds up excess fat around their liver, they can develop a condition called non-alcoholic fatty liver disease (NAFLD). Those with type 2...
The Context: We don’t need to tell you that the world is a stressful place – and everyone will have to overcome extreme challenges at some...
Even if you don’t know Derrick Rossi, PhD, you almost certainly know Moderna: the company behind mRNA vaccine technology he co-founded that is protecting millions from...
This November, National Diabetes Month yielded some early holiday cheer as the FDA approved an exciting preventative treatment for type 1 diabetes (T1D). This work was...
Why do some people get PTSD and others don’t? And what can stem cells tell us about how to develop better therapies? Understanding why certain individuals...
On October 18th and 19th, we hosted the seventeenth annual NYSCF Conference at The Rockefeller University, convening in person again after two years of virtual meetings....
A major hallmark of Parkinson’s disease is the loss of dopamine-producing neurons in the brain, which in turn causes patients to lose motor control abilities. NYSCF...
“I believe in the power of stem cell science to change the lives of patients and their families,” remarked NYSCF Interim CEO Derrick Rossi, PhD, as...
This October, family, friends, and colleagues gathered to celebrate the life of NYSCF Founding CEO Susan L. Solomon, JD, who passed away last month after a...
The New York Stem Cell Foundation (NYSCF) announced Dr. Derrick Rossi, a member of the NYSCF Board of Directors and co-founder of Moderna, as Interim CEO...
The Context: Neuropsychiatric disorders are notoriously hard to study due to their complexity and the inaccessibility of human brain tissue for experimentation. However, recent advances in...
The Context: Perhaps you’ve noticed that some people seem to get COVID-19 more easily than others. This could be due to differences in our genomes. Our...
First induced pluripotent stem cell model of PTSD offers insights into underlying genetics and opportunities for new therapies (Sign up for our upcoming webinar on November...
The Context: Post-traumatic stress disorder (PTSD) affects more than 12 million people worldwide. Only a minority of people exposed to trauma will end up with PTSD,...
